Study of various aspects of cancer, focusing on discovering new therapeutic intervention.
Novel allosteric regulation in cyclophilins, a target of the Xanthomonas citri
LNBio research suggests a negative ADAM17 regulation by thioredoxin-1 (Trx-1).
The partnership is focused on the development of innovative products and processes for the brewing industry
LNBio researcher describes new mechanisms of proteasome inhibition, a validated target against cancer.
The Center for Drug Discovery and Development follows a model in which the drug is discovered at a research facility and further developed by the industry.